Previous Article | Next Article ![]()
Journal of Virology, June 2002, p. 5866-5874, Vol. 76, No. 12
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.12.5866-5874.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Center for Cell and Gene Therapy,1 Departments of Pediatrics, Molecular Virology, and Microbiology, Baylor College of Medicine, Houston, Texas 770302
Received 27 November 2001/ Accepted 18 March 2002
|
|
|---|
|
|
|---|
The HSV amplicon, which contains these cis elements (i.e., the OriS replication origin and the a sequence), appears to be replicated in the same way as the viral genome when they are cointroduced into cells with an infectious HSV as a helper virus and can subsequently be packaged into viral particles (10). Consequently, HSV amplicons have been considered very useful reagents for studying the mechanism of HSV replication (16, 32).
A prominent feature of HSV-1 DNA replication is frequent homologous recombination. This has been traditionally studied in experimental settings where repeated sequences are either present or being introduced into a single molecule. For example, frequent homologous recombination through the repeat sequences in the viral genome leads to free inversion of the L and S segments relative to each other and the generation of four isomeric forms in equimolar proportions (7, 13). Introduction of extra inverted repeats into the viral genome can cause additional isomerization, while insertion of direct repeats can result in sequence deletion (22, 28). These phenomena are also observed in HSV amplicon constructs when they are amplified through an HSV-mediated DNA replication mechanism (6, 9, 23). Other studies have suggested that homologous recombination does not seem to require HSV DNA as the source of homology, as non-HSV DNA, such as the bacterial ampicillin gene, can also cause isomerization when it is cloned into an HSV amplicon as duplicate inverted repeats (32, 33).
Homologous recombination between different HSV molecules (called intermolecular homologous recombination [IM-HR]), on the other hand, has been less well studied. Early investigations on IM-HR were carried out by cointroducing two HSV genomes of different phenotypes into the same cell; IM-HR was identified by the occurrence of progeny virus that obtained both phenotypes (17). More recently, IM-HR has been investigated through restriction site polymorphism (5, 30). However, due to the complexity of the viral genome structure and the limitations of the detection methods used, the actual extent of the IM-HR has not been accurately estimated.
There are two possible outcomes of an IM-HR event, sequence replacement and sequence insertion (see reference 31 for a review). In sequence replacement, target sequences on one molecule are precisely replaced by sequences that are flanked by homologous regions that are present on the transfected molecule. This replacement occurs primarily by a double-crossover event during a homologous recombination event. Because of the precise nature of this type of recombination, there is no significant net change in the number of nucleotides in the target sequence. Sequence integration results from a single-crossover recombination event. Thus, in a sequence insertion, part of or the entire transfected molecule inserts into the target locus, resulting in a net increase in the number of nucleotides in the genomic sequence.
In the present report, we have studied IM-HR in a uniquely designed HSV amplicon system. We constructed two nearly identical amplicon plasmids and inactivated the ampicillin gene in one of the plasmids through a point mutation. Cotransfection of these two plasmids into cells followed by infection with a helper HSV resulted in an extremely high frequency of homologous recombination: up to 60% of the amplicon concatemers retrieved from virion particles had undergone IM-HR. This high frequency of IM-HR required that both plasmids be replicated by HSV-mediated replication machinery, as it did not occur when one or both plasmids were replicated by simian virus 40 (SV40)-mediated DNA replication even with the presence of HSV infection. The majority of the homologous recombination events resulted in sequence replacement or targeted gene repair, whereas a minority resulted in sequence insertion.
Together, these data demonstrate that IM-HR can occur at a high frequency when two homologous amplicon plasmids are replicated by an HSV-mediated replication mechanism. This finding may have significant implications for further understanding of HSV replication mechanisms and also in developing gene targeting strategies for gene therapy purposes.
|
|
|---|
Plasmid construction. The construction of the basic amplicon plasmid pW7, which carries an HSV origin of replication (oriS), a packaging signal, and a copy of the ampicillin resistance gene, has been reported previously (29, 37). To construct pW1, the kanamycin resistance gene from pVAX1 (Introgen Therapeutics, Houston, Tex.) was cut out with BspMI and XcmI and ligated into the unique NheI site of pW7 through blunt-end ligation. Plasmid pW2 was constructed from pW1 and carries a frameshift inactivation mutation in the ampicillin gene (achieved by digesting pW1 with AseI, followed by filling in the ends and ligating the plasmid). Plasmid pW2-lacZ was constructed by blunt-end ligating the 800-bp AatII-AflIII fragment of pNeb193 (Clontech), which contains the ß-galactosidase gene (lacZ), into the unique EcoRV site of pW2. To delete oriS from pW7 and pW2-lacZ, the plasmids were digested with NruI to excise the 1.1-kb oriS-containing fragment and ligated to create pW7-del and pW2-lacZ-del, respectively.
To clone the SV40 replication origin into pW7-del and pW2-lacZ-del, the SV40 origin was first cut out from pcDNA3.1(+)/Zeo (Invitrogen) through AseI digestion. The 401-bp SV40 ori-containing fragment was then cloned into the unique NruI site of either pW7-del or pW2-lacZ-del through blunt-end ligation to create pW7-SV40-ori and pW2-SV40-ori, respectively. Plasmid DNA was prepared by the alkaline lysis procedure and then purified through Qiagen ion-exchange columns in accordance with the manufacturer's protocols (Qiagen Inc., Valencia, Calif.).
Transfection, HSV infection, and DNA extraction. All the plasmid DNAs used in the experiments were grown in Escherichia coli DH10B (dam+ dcm+), released by alkaline lysis of the bacterial culture, and purified with a Qiagen-Tip 500 column. Mammalian cells were seeded in six-well plates at around 4 x 105/well and grown overnight until they reached 70 to 80% confluency. Cells were transfected with a total of 2 µg of plasmid DNA, using Lipofectamine reagent (Gibco-BRL) according to the manufacturer's instructions. For cotransfection, the plasmids were mixed at a 1:1 ratio before being added to Lipofectamine solution. The DNA was initially added to 100 µl of H2O and was then mixed with 5 µl of Lipofectamine, also in 100 µl of H2O. The mixture was left at room temperature for 30 min before it was added to 0.8 ml of serum-free medium. The medium containing the Lipofectamine formulated DNA was overlaid directly on the cells for 4 h before it was replaced with complete medium.
For the subsequent virus infection, cells were infected with 1 PFU/cell of SC16 16 h after DNA transfection and collected 24 h later after cytopathic effect (CPE) had reached
100%. For continual passage of amplicon stocks, half of the virus harvested from the cells was used to infect freshly seeded cells. DNA was extracted from either the culture supernatant or the cell pellets through different procedures according to our earlier publications (36, 37). To prepare DNA from viruses released into the culture supernatant, the virus particles were initially pelleted through high-speed centrifugation (27,000 x g for 2 h). Viral pellets were resuspended in TE (10 mM Tris, 1 mM EDTA, pH 8.0) and gently phenol extracted three times, and viral DNA was precipitated with ethanol.
For extracting extrachromosomal DNA from cell pellets, a modified Hirt's procedure was used (15). Briefly, cells were collected, washed once with phosphate-buffered saline (PBS), and then resuspended in 160 µl of buffer I (5 mM Tris [pH 7.7], 10 mM EDTA), followed by addition of 20 µl of proteinase K (10 mg/ml) and 200 µl of buffer II (5 mM Tris [pH 7.7], 10 mM EDTA, 1.2% sodium dodecyl sulfate [SDS]). The samples were incubated at 37°C for 15 min before 100 µl of 5 M NaCl was added to each tube. After overnight incubation at 4°C, the supernatant was collected by 45 min of centrifugation at 18,000 x g. The supernatants were extracted with phenol-chloroform twice before the DNA was precipitated with 2.5 volumes of ethanol. The DNA pellets were dissolved in a volume of 50 µl of H2O.
Bacterial transformation and determination of recombination frequency. E. coli DH10B cells were transformed with either undigested extracted DNA or DNA that had been digested with PacI and ligated. PacI was chosen as the enzyme to digest the amplicon concatemers because it cuts only the pW2-lacZ amplicon and its derivatives (pW2-lacZ-del and pW2-SV40-ori) but does not cut pW7 and its derivatives (pW7-del and pW7-SV40-ori). After PacI digestion, the enzyme was inactivated by heat treatment (20 min at 65°C), followed by phenol extraction and ethanol precipitation. The DNA was then ligated overnight before it was transformed into competent DH10B cells (ElectroMax; Gibco-BRL) through electroporation using an Electroporator 2510 (Eppendorf, Madison, Wis.).
Following electroporation, the E. coli cells were grown in 0.5 ml of SOC medium without antibiotics for 1 h. Equal volumes of the cells were then plated onto antibiotic selection plates (ampicillin or kanamycin) that also contained isopropylthio-ß-D-galactoside (IPTG) and 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal). Bacterial colonies were enumerated 18 h later. The blue colonies that appeared on ampicillin plates represented those that contained the recombined DNA; this was further confirmed by AseI digestion on miniprep DNA prepared from a subset of the colonies. The frequency of intermolecular homologous recombination events was determined by dividing the number of Ampr blue colonies with the number of Kanr blue colonies.
|
|
|---|
![]() View larger version (25K): [in a new window] |
FIG. 1. Experimental design and possible outcomes of IM-HR between pW7 and pW2-lacZ. The positions of the crucial components contained in the plasmids, including oriS, the a sequence that contains the HSV packaging signal (a seq), the ampicillin (AmpR) and kanamycin (KanR) resistance genes, and the lacZ gene are marked inside the circular plasmid maps. The positions of the mutated AseI site ( -AseI) and the sites of other restriction enzymes that were used for plasmid characterizations are indicated by their names outside the plasmid maps. The expected three-progeny plasmid patterns from the two outcomes of homologous recombination are depicted on the bottom. Among them, pattern I is from sequence replacement, which results in the mutated AseI site in the ampR gene's being repaired, and AseI digestion will generate two fragments, of 4.8 and 2.9 kb. Both patterns II and III are generated from sequence integration, and AseI digestion of the recombined product will generate two DNA fragments, one of them being substantially larger than that generated by sequence replacement.
|
As mentioned earlier, we predicted that there would be two consequences resulting from IM-HR between these two amplicon plasmids, sequence replacement or sequence insertion. Although both events could result in the generation of blue colonies with ampicillin resistance, these two types of homologous recombination events could be differentiated by digesting the plasmid DNA with the restriction enzyme AseI. A sequence replacement event that leads to targeted gene repair would restore the deleted AseI site in the ampicillin gene of pW2-lacZ (pattern I in Fig. 1). The recombination product, upon AseI digestion, would generate two DNA fragments of 4.8 and 2.9 kb (see Fig. 1). AseI digestion of DNA from a sequence insertion event (where part of or the entire sequence of pW7 is integrated into pW2-lacZ through homologous recombination) would still generate two DNA fragments, but depending on the position of insertion relative to the generated AseI site, one of the DNA fragments will be substantially larger than that generated by sequence replacement (patterns II and III in Fig. 1).
High frequency of IM-HR during HSV-mediated plasmid DNA replication. Purified pW7 and pW2-lacZ DNAs were mixed at a 1:1 (wt/vol) ratio, and the DNA mixture was then transfected into BHK cells by using Lipofectamine. Sixteen hours after transfection, the cells were either infected with wild-type helper HSV strain SC16 or mock infected with medium only. Twenty-four hours after virus infection, extrachromosomal DNA was extracted from the cell pellets and digested with PacI, which cuts pW2-lacZ once but does not cut pW7. Digestion of PacI therefore released the monomeric unit of pW2-lacZ (with or without homologous recombination) from the amplicon concatemer. The digested DNA was ligated after the PacI enzyme was inactivated. Competent E. coli cells were then transformed with the DNA, and equal volumes were plated onto agar plates containing X-Gal plus either ampicillin or kanamycin, and the blue colonies on the plates were enumerated.
Table 1 summarizes the results of four independent experiments. The number of Kanr blue colonies was considered to represent the total number of pW2-lacZ molecules that either had or had not undergone homologous recombination. In contrast, the number of Ampr blue colonies was considered to represent the pW2-lacZ DNA that had regained ampicillin resistance either through repairing the mutated ampicillin gene (sequence replacement) or obtaining the nonmutated ampicillin gene from pW7 (sequence insertion). Based on these assumptions, the data showed that a high percentage of pW2-lacZ (ranging from 22 to 52%) had undergone IM-HR during a single round of HSV-mediated DNA amplification. In contrast, no Ampr blue colonies were detected in the control experiments, in which the amplicon plasmids were not replicated in the cells due to the absence of HSV infection or in which the two amplicons were transfected separately and the cells were infected with HSV before the extracted DNA was mixed for PacI digestion and ligation. This result suggested that the high frequency of IM-HR between these two amplicon plasmids required HSV-mediated DNA replication. This result also excluded the possibility that the IM-HR events detected might have occurred in E. coli, as this would have resulted in a similar number of blue colonies on ampicillin plates regardless of whether the BHK cells were infected with HSV.
|
View this table: [in a new window] |
TABLE 1. Frequent IM-HR during HSV-mediated amplicon replication
|
Based on these predictions, 12 of 19 DNA samples (63%) appeared to have undergone IM-HR events resulting in gene repair (Fig. 2). The remaining seven samples (37%) displayed banding patterns consistent with sequence insertion events. For the latter class, two samples (no. 7 and 18) had the insertion in the 2.9-kb region (since the 4.8-kb band remained unchanged after AseI digestion), and the other five samples (no. 1, 4, 10, 13, and 15) had the insertion site in the 4.8-kb region (since the 2.9-kb band remained unchanged after AseI digestion). Together, these data suggest that the Ampr blue colonies truly represented the recombined amplicon pW2-lacZ and therefore validate the assumption that the enumeration of blue colonies on ampicillin plates is an easy and convenient method for quantification of IM-HR during HSV-mediated DNA replication. These data also suggest that during homologous recombination, sequence replacement occurred at a higher frequency than sequence insertion.
|
View larger version (26K): [in a new window] |
FIG. 2. Confirmation of the recombined amplicon DNA from IM-HR by AseI digestion. Nineteen blue colonies were randomly picked from ampicillin plates, and DNA was prepared by miniprep extraction. The DNA samples (lanes 1 to 19) as well as the plasmid DNA of pW7 (lane 20) and pW2-lacZ (lane 21) were digested with AseI and electrophoresed on a 0.8% agarose gel. DNA size markers (lanes M) are the 1-kb DNA ladder.
|
![]() View larger version (72K): [in a new window] |
FIG. 3. Further confirmation of the different IM-HR patterns. Two samples were randomly chosen from each of the three patterns of IM-HR shown in Fig. 2 (pattern I, sequence replacement; pattern II, sequence insertion in the 2.9-kb AseI fragment; pattern III, sequence insertion in the 4.8-kb AseI fragment) and numbered from 1 to 6. The DNA was digested with the indicated restriction enzymes. (A) List of the expected DNA fragments and their sizes. (B) Actual results from agarose gel electrophoresis. DNA markers (lanes M) are the 1-kb ladder.
|
|
View this table: [in a new window] |
TABLE 2. IM-HR frequency and patterns in samples of different preparationsa
|
To determine the relative frequency of the three different patterns of IM-HR in each of the DNA preparations, blue colonies were randomly picked from ampicillin plates, and DNA was prepared and digested with AseI. The results again showed that all the blue colonies tested contained amplicon plasmid DNA that had undergone IM-HR. However, there was a significant difference in the frequency of individual types of IM-HR (Table 2). The DNA from both the P1 cell pellet fraction (PacI digested and ligated) and the uncut first-round cell pellet fraction had a much higher percentage of sequence replacement than the DNA from the first-round cell pellet fraction that had been digested with PacI and ligated; approximately 90% of colonies from these two groups were found to have had sequence replacement, in contrast to the 63% detected in the DNA of the first-round cell pellet. The reasons for this difference are not yet clear.
One assumption made in these experiments was that the DNA obtained from amplicons that had been passaged once represented replicated DNA. To confirm this, the DNA from the P1 cell pellet fraction was digested with either AseI alone or AseI together with DpnI, which digests any unreplicated plasmid DNA. The DNA was then ligated and transformed into E. coli. The number of blue colonies on ampicillin plates remained essentially unchanged regardless of whether the DNA had been digested with DpnI (data not shown), indicating that the DNA that had undergone IM-HR was indeed mostly newly synthesized.
Determination of IM-HR frequency in cells of different origins. To determine if the observed high frequency of IM-HR during HSV-mediated amplicon replication could also occur in other types of cells, we repeated the experiment described in Table 1 in a panel of cells of different species and origins that sufficiently support HSV replication. The DNA used for bacterial transformation was from the first-round cell pellet fraction and had been digested with PacI and ligated. The results showed that the frequency of IM-HR was highest in BHK cells, whereas the IM-HR frequency in other cells tested was lower; around 15% of the amplicon DNA amplified in these cells underwent IM-HR (Table 3). Again, these results were confirmed by AseI digestion of DNA prepared from a fraction of the blue colonies present on ampicillin plates (data not shown). These results indicate that high-frequency IM-HR mediated by the HSV replication machinery is a universal phenomenon that occurs in a variety of mammalian cells.
|
View this table: [in a new window] |
TABLE 3. Frequency of HSV-mediated IM-HR in different cell lines
|
|
View this table: [in a new window] |
TABLE 4. oriS is required in both amplicon plasmids for efficient IM-HR
|
We initially tested these two SV40 ori-containing plasmids for their ability to be replicated in COS-1 cells and found that the large T antigen provided by this cell could amplify both plasmids more than 1,000-fold after they were transfected into the cells (data not shown). These two plasmids were then mixed and transfected into COS-1 cells in the presence or absence of HSV superinfection. The DNA was extracted and treated the same way as described for the experiment presented in Table 1 and then used to transform competent E. coli. The results in Table 5 show that the frequency of IM-HR between these two plasmids during SV40-mediated replication was very low compared with that of amplicon plasmids replicated by the HSV mechanism. In addition, HSV superinfection seemed to only marginally enhance the IM-HR frequency when two SV40 ori-containing plasmids were used. Overall, these results indicate that the generation of high-frequency IM-HR during HSV-mediated amplicon replication requires, at least in part, the participation of the HSV replication machinery.
|
View this table: [in a new window] |
TABLE 5. IM-HR during SV40-mediated plasmid DNA replication
|
|
|
|---|
Studies by our laboratory and others have shown that HSV replicative intermediates very frequently contain adjacent genomic units with L and S segments in different orientations (called concatemers with internal segment isomerization, or concatemer-ISI), from which all the four possible HSV isomers can be generated in equal molar ratios through random cleavage and packaging (1, 21, 25, 36). Subsequent studies have indicated that concatemer-ISI may be generated through IM-HR, as mixed infection with two viruses can generate replicative intermediates in which the two viral genomes are frequently interspersed along a single concatemer (27). However, due to the extremely large size of the molecules analyzed in those experiments, the mechanism for IM-HR could not be elucidated. The results presented in this work seems to indicate that these unique HSV concatemers may have been generated through the two mechanisms that we have elucidated in the present study, through either sequence replacement or sequence insertion. If this indeed is the case, it is highly likely that such frequent IM-HR may contribute directly to HSV genome isomerization.
It has been demonstrated that HSV-mediated DNA replication is specifically required for high-frequency homologous recombination between repeats in a single molecule (9, 33). Our data demonstrate that this is also the case during IM-HR. Our data also indicate that both amplicon plasmids need to be replicated by an HSV-mediated replication mechanism in order to generate high-frequency IM-HR. However, although high-frequency homologous recombination through the repeats in a single molecule has been demonstrated during SV40-mediated plasmid replication in the presence of HSV superinfection (3), this has been proven not to be the case for IM-HR. These results, together with our earlier work on HSV replication-mediated isomerization (32), suggest that HSV-1 replication-mediated homologous recombination, either intramolecular or intermolecular, is an integrated part of the viral DNA replication mechanism. However, our data suggest that inter- and intramolecular HR may employ slightly different mechanisms in different experimental settings.
Our analysis of IM-HR in different cell lines showed that the frequency of IM-HR between the two amplicons was substantially higher in BHK cells than in COS-1, Vero, or HEK-293 cells. Studies by Yao and Elias have also revealed that BHK cells are more efficient than other cells, such as BALB/c 3T3 cells, at supporting homologous recombination on repeated sequences in plasmid DNA (35). This suggests that in addition to viral proteins, certain cellular proteins may also be required for the efficient generation of IM-HR; these cellular proteins may be more abundantly expressed in BHK cells than in the other cells we have tested. Nonetheless, the frequency of IM-HR in COS-1 and Vero cells is still very significant (reaching 15%), indicating that IM-HR during HSV-mediated DNA replication is a specific event that is directly linked to the mechanism of HSV DNA replication itself. Thus, cellular factors may augment but do not dictate this process.
The detection of relatively abundant blue bacterial colonies, which are assumed to represent the circular products of IM-HR, in the absence of PacI digestion and ligation cannot be explained by the rolling-circle mechanism of replication. Two possibilities may have resulted in the generation of these circular molecules: they may have been generated from the concatemers through recombination, or they may have been generated from a circle-to-circle (theta) replication mechanism with the participation of frequent homologous recombination. A recent study in our laboratory showed that during lytic HSV infection, theta replication may indeed be a part of the viral replication strategies (Fu et al., submitted for publication). In addition, characterization of the amplicon DNA of IM-HR has identified a discrepancy between DNA extracted from different stages of amplicon preparation: the DNA extracted from cells harboring passaged amplicons has a twofold higher incidence of sequence replacement than the DNA extracted from cells of first-round transfection-infection. The reason for this is currently unclear. One possibility is that the DNA from cells of transfection-infection may contain a much higher proportion of products from circle-to-circle replication, and in those products, sequence insertion may be more frequent than that from rolling-circle replication.
It is expected that in addition to its possible role in the generation of HSV genome isomerization, high-frequency IM-HR may also play some other important roles during HSV DNA replication and the virus life cycle. One possibility is that the IM-HR may help maintain the integrity of the viral genome through repairing any mutated or damaged HSV DNA that may occur during the rapid replication of viral DNA. Also, from an evolutionary point of view, the high frequency of IM-HR may have helped the virus to quickly adapt to the changing environment of the host through free and rapid accumulation of mutations or extra DNA sequences from each individual viral genome. Alternatively, it is also possible that the same mechanism may have contributed to the diversity of the viral genome in the many different strains of virus that existed in nature.
The demonstration that oriS must be present in both amplicon plasmids to generate a high frequency of IM-HR indicates that the virus-encoded polypeptides (in particular, the viral proteins essential for origin-dependent DNA replication) may play a key role. Dissecting the genes or mechanisms involved in this high frequency of IM-HR may help in designing a better strategy for gene therapy for many inherited genetic disorders, such as cystic fibrosis and hemophilia, which are caused by defined mutations in single disease genes. Current gene therapy strategies that are considered for such diseases usually involve the introduction of an additional, mutation-free copy of the disease-causing gene into the cells of an appropriate tissue. However, there are inherent problems with such gene augmentation strategies, including inappropriate or unstable expression of the new gene, and safety concerns arising from random integration into the host genome. Repair of the mutated endogenous gene through homologous recombination would avoid these problems. The efficiency of current gene targeting approaches, however, is generally low, and this has prevented them from being widely considered for gene therapy (34). Further understanding of the mechanism of HSV-mediated high-frequency IM-HR, in particular, adapting the efficient targeted gene repair mechanism to popular gene delivery vectors, will greatly benefit this field. Also, our current understanding of homologous recombination, both the genetics and the biochemistry of the process, is primarily based on observations made in E. coli. HSV-mediated IM-HR of amplicons may serve as an attractive model for studying homologous recombination in a mammalian system, and the knowledge obtained from it will likely provide significant input into the gene therapy field.
We thank Malcolm K. Brenner for continuous support and Sara Evans for careful reading of the manuscript.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»